Charmaine Ansari, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1225 Graham Rd, Ste 2320c, Florissant, MO 63031 Phone: 314-953-6801 Fax: 314-953-6119 |
News Archive
ev3 today announced that its majority-owned subsidiary Micro Therapeutics has received pre-market application (PMA) approval from the U.S. Food and Drug Administration (FDA) to commercialize its Onyx Liquid Embolic System (Onyx) for the treatment of arterio-venous malformations (AVMs), a vascular disorder in the brain.
Enzymes, the workhorses of chemical reactions in cells, lead short and brutal lives. They cleave and assemble proteins and metabolize compounds for a few hours, and then they are spent. This sad fact of nature has limited the possibilities of harnessing enzymes as catalytic tools outside the cell, in uses that range from biosensing to toxic waste cleanup.
Oramed Pharmaceuticals Inc., a developer of oral drug delivery systems, announced today that it has filed a provisional patent application with the United States Patent and Trademark Office for a combination therapy of its lead compound, ORMD-0801 in combination with its oral exenatide formulation, ORMD-0901. There is no such approved combination product available on the market today.
The production of sperm - otherwise known as spermatogenesis - generates more than 1,000 sperm per second in normal males.
British Columbia has the healthiest population in Canada, and along with Ontario ranks higher than most advanced countries in The Conference Board of Canada's first How Canada Performs: Health report card that compares the health performance of Canada, the provinces, territories, and 15 peer countries.
› Verified 1 days ago